Gefitinib

Product Description

Gefitinib (CAS Number: 184475-35-2)

Geftinib is an epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor and is used for the treatment of Non-small cell Lung Cancer in people who have already been treated with certain other chemotherapy medications and have not improved or whose condition has worsened.
Chemical formula : C₂₂H₂₄ClFN₄O₃
Chemical name: 4-quinazolinamide, N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(4-morpholinyl)propoxy], (3-Cchloro-4-fluoro-phenyl)-[7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-yl)amine, 4-(3'-chloro-4'-fluoroanilo)-7-methoxy-6-(3-morpholinopropoxy) quinazoline

Molecular weight: 446.90 
Melting point :119-120⁰C
Boiling point : 586.8 °C at 760 mmHg
Flash point    : 308.7 °C
Appearance : white or off-white powder
Assay  :99%
Package:  5/10/25kg / fibre drum